Clinical trials recruiting for Advanced Malignant Neoplasm
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AMXI-5001:Dose Escalation Phase I | 1 |
| AMXI-5001:Dose Expansion Phase II | 1 |
| IAP0971 | 1 |
| Pembrolizumab | 1 |
| rezatapopt | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Colorado | 1 |
| Connecticut | 1 |
| Delaware | 1 |
| Florida | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Nebraska | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Related conditions
Trials recruiting for Advanced Malignant Neoplasm often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Malignant Neoplasm trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.